Pro-calcitonin Marker as Indicator of Ischemia in Patients With Complicated Coronary Intervention.
The aim of this study is to determine on preliminary basis weather an elevated pro-calcitonin level can be used to assess ischemia as a result of coronary artery complications during percutaneous coronary intervention (PCI).
|Study Design:||Time Perspective: Prospective|
|Official Title:||Utility of Pro-calcitonin as an Indicator of Ischemia in Patients Undergoing Percutaneous Coronary Intervention With Subsequent Coronary Complications.|
- Pro-calcitonin blood level [ Time Frame: "0,24 hours post cardiac intervention" ] [ Designated as safety issue: No ]
|Study Start Date:||May 2012|
|Estimated Study Completion Date:||May 2014|
|Estimated Primary Completion Date:||April 2014 (Final data collection date for primary outcome measure)|
patients with coronary complication and patients without coronary complications.
pro-calcitonin will be measured in both groups to see if any correlation.
Pro-calcitonin is a type of protein found in the blood. This protein has recently be found to be elevated in patients with diseases of the arteries of the heart such as heart attack.
Percutaneous coronary intervention (PCI) is widely used in the treatment of many patients with blockage in the arteries of the heart.
the investigators normally used a marker called troponin after cardiac catheterization. However, this marker may not be specific.
Pro-calcitonin has been found to be a useful marker for the detection of myocardial injury. the value of Pro-calcitonin as a marker for the identification of myocardial damage undergoing PCI has not yet been studied.
|United States, New Jersey|
|Saint Michael's Medical Center|
|Newark, New Jersey, United States, 07102|
|Principal Investigator:||Habib Habib, MD||Saint Michael's Medical Center|
|Study Director:||Fayez Shamoon, MD,FACC||Saint Michael's Medical Center|
|Study Chair:||yaser elnhar, MD||Saint Michael's Medical Center|
|Study Chair:||Vincent Debari, PhD||Saint Michael's Medical Center|
|Study Chair:||Ashraf Jmeian, MD||Saint Michael's Medical Center|
|Study Chair:||Ahmad Isbitan, MD||Saint Michael's Medical Center|